Ptc Therapeutics reported $-63182000 in EBITDA for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -33.14M 79.36M
Alnylam Pharmaceuticals ALNY:US $ -181.59M 44.32M
Amgen AMGN:US $ 3004M 337M
Biogen BIIB:US $ 1075.7M 401M
Biomarin Pharmaceutical BMRN:US $ 64.42M 7.75M
Bluebird Bio BLUE:US $ -99.42M 19.92M
Cytokinetics CYTK:US $ -9.47M 67.05M
Daiichi Sankyo 4568:JP Y 49252M 84953M
Enanta Pharmaceuticals ENTA:US $ -31.82M 1.2M
Esperion Therapeutics ESPR:US $ -52226000 9.39M
Gilead Sciences GILD:US $ 2585M 837M
Intercept Pharmaceuticals ICPT:US $ -10.87M 0.98M
IONIS PHARMACEUT IONS:US $ -81.13M 27.92M
Ironwood Pharmaceuticals IRWD:US $ 56.02M 2.19M
Karyopharm Therapeutics KPTI:US $ -42759000 8.35M
Novartis NOVN:VX SF 4660M 108M
Pfizer PFE:US $ 12921M 1739M
Ptc Therapeutics PTCT:US $ -63.18M 2.97M
Puma Biotechnology PBYI:US $ 14.28M 12.77M
Sangamo Biosciences SGMO:US $ -42.85M 0.42M
Sarepta Therapeutics SRPT:US $ -201.24M 125.08M
Ultragenyx Pharmaceutical RARE:US $ -137.11M 4.57M
Vertex Pharmaceuticals VRTX:US $ 1156.6M 87.3M
Xencor XNCR:US $ -25.78M 54.42M
YTE INCY:US $ 276.8M 132.69M